Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?

被引：38

作者：

Rossi, Ernesto ^{[1
]}

Schinzari, Giovanni ^{[1
,2
]}

Zizzari, Ilaria Grazia ^{[3
]}

Maiorano, Brigida Anna ^{[1
]}

Pagliara, Monica Maria ^{[4
]}

Sammarco, Maria Grazia ^{[4
]}

Fiorentino, Vincenzo ^{[5
]}

Petrone, Gianluigi ^{[5
]}

Cassano, Alessandra ^{[1
,2
]}

Rindi, Guido ^{[5
]}

Bria, Emilio ^{[1
,2
]}

Blasi, Maria Antonietta ^{[4
]}

Nuti, Marianna ^{[3
]}

Tortora, Giampaolo ^{[1
,2
]}

机构：

[1] Fdn Policlin Univ, A Gemelli IRCCS, Med Oncol, I-00168 Rome, Italy

[2] Univ Cattolica Sacro Cuore, Med Oncol, I-00168 Rome, Italy

[3] Sapienza Univ, Dept Expt Med, Lab Tumor Immunol & Cell Therapy, Policlin Umberto 1, I-00162 Rome, Italy

[4] Fdn Policlin Univ, A Gemelli IRCCS, Ophtalmol, I-00168 Rome, Italy

[5] Fdn Policlin Univ, A Gemelli IRCCS, Pathol, I-00168 Rome, Italy

来源：

CANCERS | 2019年 / 11卷 / 08期

关键词：

immunotherapy; uveal melanoma; checkpoint inhibitors; PD-L1; nivolumab; pembrolizumab; ipilimumab; IDO; TUMOR-INFILTRATING LYMPHOCYTES; MIGRATION-INHIBITORY FACTOR; CANDIDATE PROTEINS GP100; ANTIGEN EXPRESSION; ADOPTIVE TRANSFER; HLA EXPRESSION; CELL-ACTIVITY; MONOSOMY; CLASS-I; IPILIMUMAB;

D O I：

10.3390/cancers11081055

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

No standard treatment has been established for metastatic uveal melanoma (mUM). Immunotherapy is commonly used for this disease even though UM has not been included in phase III clinical trials with checkpoint inhibitors. Unfortunately, only a minority of patients obtain a clinical benefit with immunotherapy. The immunological features of mUM were reviewed in order to understand if immunotherapy could still play a role for this disease.

引用

页数：12

共 50 条

[41] Uveal melanoma
Nature Reviews Disease Primers, 6 (1)
[42] Uveal Melanoma
Pfeffer, Ulrich
CANCERS, 2019, 11 (12)
[43] UVEAL MELANOMA
BOAZIZ, C
MAZERON, JJ
MORERE, JF
BREAU, JL
ISRAEL, L
BULLETIN DU CANCER, 1993, 80 (07) : 577 - 583
[44] Uveal melanoma
Spagnolo, Francesco
Caltabiano, Graziano
Queirolo, Paola
CANCER TREATMENT REVIEWS, 2012, 38 (05) : 549 - 553
[45] UVEAL MELANOMA
CONLON, MR
ALBERT, DM
INTERNATIONAL OPHTHALMOLOGY CLINICS, 1993, 33 (02) : 67 - 76
[46] Uveal melanoma
Martine J. Jager
Carol L. Shields
Colleen M. Cebulla
Mohamed H. Abdel-Rahman
Hans E. Grossniklaus
Marc-Henri Stern
Richard D. Carvajal
Rubens N. Belfort
Renbing Jia
Jerry A. Shields
Bertil E. Damato
Nature Reviews Disease Primers, 6
[47] Uveal melanoma
Munk, PL
RADIOLOGY, 1997, 204 (03) : 874 - 875
[48] Uveal melanoma
Kashyap, Seema
Meel, Rachna
Singh, Lata
Singh, Mithalesh
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2016, 33 (03) : 141 - 147
[49] Survival of Uveal Melanoma Patients Treated With Combination and Single-Agent Immunotherapy
Caldwell, Reece
Mason, Robert
Atkinson, Victoria
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 140 - 141
[50] Immunotherapy response and resistance in patients with advanced uveal melanoma: a retrospective cohort study
Maurer, Alexander
Clerici, Giulio
Schaab, Jan A.
Cheng, Phil F.
Mihic-Probst, Daniela
Mader, Cacilia
Messerli, Michael
Huellner, Martin W.
Dummer, Reinhard
Dimitriou, Florentia
CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)

← 1 2 3 4 5 →